Cargando…

A Fluorescence Polarization-Based High-Throughput Screen to Identify the First Small-Molecule Modulators of the Human Adenylyltransferase HYPE/FICD

The covalent transfer of the AMP portion of ATP onto a target protein—termed adenylylation or AMPylation—by the human Fic protein HYPE/FICD has recently garnered attention as a key regulatory mechanism in endoplasmic reticulum homeostasis, neurodegeneration, and neurogenesis. As a central player in...

Descripción completa

Detalles Bibliográficos
Autores principales: Camara, Ali, George, Alyssa, Hebner, Evan, Mahmood, Anika, Paluru, Jashun, Mattoo, Seema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582957/
https://www.ncbi.nlm.nih.gov/pubmed/32992526
http://dx.doi.org/10.3390/ijms21197128
_version_ 1783599310428962816
author Camara, Ali
George, Alyssa
Hebner, Evan
Mahmood, Anika
Paluru, Jashun
Mattoo, Seema
author_facet Camara, Ali
George, Alyssa
Hebner, Evan
Mahmood, Anika
Paluru, Jashun
Mattoo, Seema
author_sort Camara, Ali
collection PubMed
description The covalent transfer of the AMP portion of ATP onto a target protein—termed adenylylation or AMPylation—by the human Fic protein HYPE/FICD has recently garnered attention as a key regulatory mechanism in endoplasmic reticulum homeostasis, neurodegeneration, and neurogenesis. As a central player in such critical cellular events, high-throughput screening (HTS) efforts targeting HYPE-mediated AMPylation warrant investigation. Herein, we present a dual HTS assay for the simultaneous identification of small-molecule activators and inhibitors of HYPE AMPylation. Employing the fluorescence polarization of an ATP analog fluorophore—Fl-ATP—we developed and optimized an efficient, robust assay that monitors HYPE autoAMPylation and is amenable to automated, high-throughput processing of diverse chemical libraries. Challenging our pilot screen with compounds from the LOPAC, Spectrum, MEGx, and NATx libraries yielded 0.3% and 1% hit rates for HYPE activators and inhibitors, respectively. Further, these hits were assessed for dose-dependency and validated via orthogonal biochemical AMPylation assays. We thus present a high-quality HTS assay suitable for tracking HYPE’s enzymatic activity, and the resultant first small-molecule manipulators of HYPE-promoted autoAMPylation.
format Online
Article
Text
id pubmed-7582957
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75829572020-10-28 A Fluorescence Polarization-Based High-Throughput Screen to Identify the First Small-Molecule Modulators of the Human Adenylyltransferase HYPE/FICD Camara, Ali George, Alyssa Hebner, Evan Mahmood, Anika Paluru, Jashun Mattoo, Seema Int J Mol Sci Article The covalent transfer of the AMP portion of ATP onto a target protein—termed adenylylation or AMPylation—by the human Fic protein HYPE/FICD has recently garnered attention as a key regulatory mechanism in endoplasmic reticulum homeostasis, neurodegeneration, and neurogenesis. As a central player in such critical cellular events, high-throughput screening (HTS) efforts targeting HYPE-mediated AMPylation warrant investigation. Herein, we present a dual HTS assay for the simultaneous identification of small-molecule activators and inhibitors of HYPE AMPylation. Employing the fluorescence polarization of an ATP analog fluorophore—Fl-ATP—we developed and optimized an efficient, robust assay that monitors HYPE autoAMPylation and is amenable to automated, high-throughput processing of diverse chemical libraries. Challenging our pilot screen with compounds from the LOPAC, Spectrum, MEGx, and NATx libraries yielded 0.3% and 1% hit rates for HYPE activators and inhibitors, respectively. Further, these hits were assessed for dose-dependency and validated via orthogonal biochemical AMPylation assays. We thus present a high-quality HTS assay suitable for tracking HYPE’s enzymatic activity, and the resultant first small-molecule manipulators of HYPE-promoted autoAMPylation. MDPI 2020-09-27 /pmc/articles/PMC7582957/ /pubmed/32992526 http://dx.doi.org/10.3390/ijms21197128 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Camara, Ali
George, Alyssa
Hebner, Evan
Mahmood, Anika
Paluru, Jashun
Mattoo, Seema
A Fluorescence Polarization-Based High-Throughput Screen to Identify the First Small-Molecule Modulators of the Human Adenylyltransferase HYPE/FICD
title A Fluorescence Polarization-Based High-Throughput Screen to Identify the First Small-Molecule Modulators of the Human Adenylyltransferase HYPE/FICD
title_full A Fluorescence Polarization-Based High-Throughput Screen to Identify the First Small-Molecule Modulators of the Human Adenylyltransferase HYPE/FICD
title_fullStr A Fluorescence Polarization-Based High-Throughput Screen to Identify the First Small-Molecule Modulators of the Human Adenylyltransferase HYPE/FICD
title_full_unstemmed A Fluorescence Polarization-Based High-Throughput Screen to Identify the First Small-Molecule Modulators of the Human Adenylyltransferase HYPE/FICD
title_short A Fluorescence Polarization-Based High-Throughput Screen to Identify the First Small-Molecule Modulators of the Human Adenylyltransferase HYPE/FICD
title_sort fluorescence polarization-based high-throughput screen to identify the first small-molecule modulators of the human adenylyltransferase hype/ficd
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582957/
https://www.ncbi.nlm.nih.gov/pubmed/32992526
http://dx.doi.org/10.3390/ijms21197128
work_keys_str_mv AT camaraali afluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT georgealyssa afluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT hebnerevan afluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT mahmoodanika afluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT palurujashun afluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT mattooseema afluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT camaraali fluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT georgealyssa fluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT hebnerevan fluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT mahmoodanika fluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT palurujashun fluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd
AT mattooseema fluorescencepolarizationbasedhighthroughputscreentoidentifythefirstsmallmoleculemodulatorsofthehumanadenylyltransferasehypeficd